The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] Third-quarter results for Medtronic (NYSE:MDT) today included a timeline for a planned label ...

The company’s MiniMed insulin pump increased its customer base and strengthened its continuous glucose monitor (CGM) attachment rates, as per the earnings release. Medtronic has not changed its fiscal ...

Sensors can be worn up to 15 days. Medtronic's Guardian Connect CGM, which is approved for people with diabetes ages 14 and up, can alert patients of potential high or low glucose events up to 60 ...

After hours: March 13 at 7:58:52 PM EDT Loading Chart for MDT ...

Medtronic posted a strong profit for Q3 of fiscal ... its customer base and strengthened its continuous glucose monitor (CGM) attachment rates, as per the earnings release.

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Medtronic missed Wall Street's fiscal 2025 Q3 revenue estimate but beat earnings expectations. The company's revenue miss appears to be primarily related to a temporary change in distributor ...

Medtronic is a diversified medical device maker with a global footprint. Its reliably growing dividend has helped fuel its stock performance for decades. Its shares are reasonably valued for the ...

A clinician uses Medtronic's pulsed field ablation system for treating atrial fibrillation last month. On Tuesday, Medtronic reported adjusted quarterly net profit of $1.8 billion on $8.3 billion ...

Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release ...